ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Potential use of the S-protein-Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019

Feng, Long; Fu, Shihui; Zhang, Pei; Zhang, Yujie; Zhao, Yali*; Yao, Yao*; Luo, Leiming*; Ping, Ping*北京大学; 北京理工大学; 南方医科大学; y
Frontiers in Public Health2022-11-28DOI: 10.3389/fpubh.2022.1050034
8阅读
引用收藏
分享

摘要

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes coronavirus disease 2019 (COVID-19), infects humans through a strong interaction between the viral spike protein (S-protein) and angiotensin converting enzyme 2 (ACE2) receptors on the cell surface. The infection of host lung cells by SARS-CoV-2 leads to clinical symptoms in patients. However, ACE2 expression is not restricted to the lungs; altered receptors have been found in the nasal and oral mucosa, vessel, brain, pancreas, gastrointestinal tract, kidney, and heart. The future of COVID-19 is uncertain, however, new viral variants are likely to emerge. The SARS-CoV-2 Omicron variant has a total of 50 gene mutations compared with the original virus; 15 of which occur in the receptor binding domain (RBD). The RBD of the viral S-protein binds to the human ACE2 receptor for viral entry. Mutations of the ACE2-RBD interface enhance tight binding by increasing hydrogen bond interactions and expanding the accessible surface area. Extracorporeal membrane oxygenation, hyperbaric oxygen, and aggressive dialysis for the treatment of COVID-19 have shown various degrees of clinical success. The use of decoy receptors based on the ACE2 receptor as a broadly potent neutralizer of SARS-CoV-2 variants has potential as a therapeutic mechanism. Drugs such as 3E8 could block binding of the S1-subunit to ACE2 and restrict the infection of ACE2-expressing cells by a variety of coronaviruses. Here, we discuss the development of ACE2-targeted strategies for the treatment and prevention of COVID-19.

学科与关键词

关键词
angiotensin converting enzyme 2coronavirus disease 2019receptor binding domainS-protein
相关
加载中…
  • Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection
    Lu, Mengjia; Yao, Weitong; Li, Yujun*; Ma, Danting; Zhang, Zhaoyong; Wang, Haimin; Tang, Xiaojuan; Wang, Yanqun; Li, Chao; Cheng, Dechun; Lin, Hua; Yin, Yandong*; Zhao, Jincun*; Zhong, Guocai*Microbiology Spectrum, 2023, 11(4).
  • Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
    Zhang, Zhaoyong; Zeng, Eric; Zhang, Lu; Wang, Weiming; Jin, Yingkang; Sun, Jiye; Huang, Shuxiang; Yin, Wenguang; Dai, Jun; Zhuang, Zhen; Chen, Zhao; Sun, Jing; Zhu, Airu; Li, Fang; Cao, Weitao; Li, Xiaobo; Shi, Yongxia; Gan, Mian; Zhang, Shengnan; Wei, Peilan; Huang, Jicheng; Zhong, Nanshan; Zhong, Guocai*; Zhao, Jingxian*; Wang, Yanqun*; Shao, Weihui*; Zhao, Jincun*Cell Discovery, 2021, 7(1): 65.被引 40
  • Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
    Han, Pengcheng; Li, Linjie; Liu, Sheng; Wang, Qisheng; Zhang, Di; Xu, Zepeng; Han, Pu; Li, Xiaomei; Peng, Qi; Su, Chao; Huang, Baihan; Li, Dedong; Zhang, Rong; Tian, Mingxiong; Fu, Lutang; Gao, Yuanzhu; Zhao, Xin; Liu, Kefang; Qi, Jianxun*; Gao, George F.*; Wang, Peiyi*Cell, 2022, 185(4): 630-+.被引 260
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Public Health
发表日期
2022-11-28
卷期
第 10 卷
页码
1050034
DOI
10.3389/fpubh.2022.1050034
期刊等级
3区
成果收录
SSCI · SCIE

作者

  • F

    Feng, Long (第一作者)

    chinese peoples liberat army gen hosp

  • F

    Fu, Shihui

    chinese peoples liberat army gen hosp

查看全部 8 位作者收起作者
  • Z

    Zhang, Pei

    beijing inst technol

  • Z

    Zhang, Yujie

    southern med univ

  • Z

    Zhao, Yali (通讯)

    chinese peoples liberat army gen hosp

  • Y

    Yao, Yao (通讯)

    peking univ

  • L

    Luo, Leiming (通讯)

    chinese peoples liberat army gen hosp

  • P

    Ping, Ping (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417